Order Article Reprints

Abduljawad AA, Alkinani KB, Zaakan A, AlGhamdi AS, Hamdoon AAE, Alshanbari BH, Alshehri AA, Alluhaybi BB, Alqashi SOI, Abduljawad RA. Targeting Amyloid-β Proteins as Potential Alzheimer’s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health. Pharmaceuticals. 2025; 18(11):1731. https://doi.org/10.3390/ph18111731

Abduljawad, Asaad Abdulrahman, Khadijah B. Alkinani, Aysha Zaakan, Abeer S. AlGhamdi, Alashary Adam Eisa Hamdoon, Batool H. Alshanbari, Ahmed Abdullah Alshehri, Badria Bakheet Alluhaybi, Shahad Othman Ibrahim Alqashi, and Ryan Abdulrahman Abduljawad. 2025. "Targeting Amyloid-β Proteins as Potential Alzheimer’s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health" Pharmaceuticals 18, no. 11: 1731. https://doi.org/10.3390/ph18111731

Abduljawad, A. A., Alkinani, K. B., Zaakan, A., AlGhamdi, A. S., Hamdoon, A. A. E., Alshanbari, B. H., Alshehri, A. A., Alluhaybi, B. B., Alqashi, S. O. I., & Abduljawad, R. A. (2025). Targeting Amyloid-β Proteins as Potential Alzheimer’s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health. Pharmaceuticals, 18(11), 1731. https://doi.org/10.3390/ph18111731